Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability

Eur J Med Chem. 2022 Jan 5:227:113903. doi: 10.1016/j.ejmech.2021.113903. Epub 2021 Oct 9.

Abstract

Further clinical development of PF74, a lead compound targeting HIV-1 capsid, is impeded by low antiviral activity and inferior metabolic stability. By modifying the benzene (region I) and indole of PF74, we identified two potent compounds (7m and 7u) with significantly improved metabolic stability. Compared to PF74, 7u displayed greater metabolic stability in human liver microsomes (HLMs) with half-life (t1/2) 109-fold that of PF74. Moreover, mechanism of action (MOA) studies demonstrated that 7m and 7u effectively mirrored the MOA of compounds that interact within the PF74 interprotomer pocket, showing direct and robust interactions with recombinant CA, and 7u displaying antiviral effects in both the early and late stages of HIV-1 replication. Furthermore, MD simulation corroborated that 7u was bound to the PF74 binding site, and the results of the online molinspiration software predicted that 7m and 7u had desirable physicochemical properties. Unexpectedly, this series of compounds exhibited better antiviral activity than PF74 against HIV-2, represented by compound 7m whose anti-HIV-2 activity was almost 5 times increased potency over PF74. Therefore, we have rationally redesigned the PF74 chemotype to inhibitors with novel structures and enhanced metabolic stability in this study. We hope that these new compounds can serve as a blueprint for developing a new generation of HIV treatment regimens.

Keywords: Benzothiazole; Capsid inhibitor; HIV-1; Metabolic stability; Phenylalanine.

MeSH terms

  • Anti-HIV Agents / chemistry
  • Anti-HIV Agents / metabolism
  • Anti-HIV Agents / pharmacology*
  • Benzothiazoles / chemistry
  • Benzothiazoles / metabolism
  • Benzothiazoles / pharmacology*
  • Capsid Proteins / antagonists & inhibitors*
  • Capsid Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Drug Design*
  • HIV-1 / drug effects*
  • Humans
  • Microbial Sensitivity Tests
  • Microsomes, Liver / chemistry
  • Microsomes, Liver / metabolism
  • Molecular Structure
  • Phenylalanine / chemistry
  • Phenylalanine / metabolism
  • Phenylalanine / pharmacology*
  • Structure-Activity Relationship
  • Virus Replication / drug effects

Substances

  • Anti-HIV Agents
  • Benzothiazoles
  • Capsid Proteins
  • Phenylalanine
  • benzothiazole